Condition
HIE
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
P 1 (3)
P 2 (1)
Trial Status
Recruiting2
Completed1
Not Yet Recruiting1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06195345RecruitingPrimary
Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
NCT05853601Phase 1Recruiting
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
NCT06429007Phase 1Enrolling By Invitation
A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury
NCT07411911Phase 1Not Yet RecruitingPrimary
Hydrogen In Neonatal Encephalopathy (HIE) Trial
NCT04705142Phase 2CompletedPrimary
Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE)
Showing all 5 trials